サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565707

In-vitro転写テンプレートの世界市場：製品別、用途別、疾患タイプ別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）

In-vitro Transcription Templates Market, By Product, By Application, By Disease Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
In-vitro転写テンプレートの世界市場：製品別、用途別、疾患タイプ別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

世界のIn-vitro転写テンプレートの市場規模は、2023年に2億5,143万米ドルとなり、2024年～2032年にCAGR21.09%で拡大すると予測されています。

In-vitro転写テンプレート市場-市場力学

RNAベースの治療薬やワクチンの需要拡大、バイオテクノロジー研究の増加も市場需要を促進する見込み

低分子干渉RNA（siRNA）やアンチセンスオリゴヌクレオチド（ASO）を含むRNAベースの治療薬の開発により、高品質なRNA生産に対する需要が高まっています。ファイザー・バイオンテックやModernaのようなCOVID-19用に開発されたmRNAワクチンは、In-vitro転写（IVT）テンプレートに対する関心を著しく高めています。mRNAワクチンを迅速に設計・製造できることから、In-vitro転写は医薬品開発において極めて重要なものとなっています。CRISPR-Cas9のような遺伝子編集ツールの台頭は、ゲノム編集用途に不可欠なガイドRNA（gRNA）の生成にIn-vitro転写を利用しています。

個別化医療が発展するにつれて、がん免疫療法のような個別化治療のためのテーラーメイドRNAを生産する能力が、効率的なIVTテンプレート技術の需要を促進しています。バイオセンサー、生物工学用途、新規生物学的回路用のRNAを効率的に生産する必要性は、転写テンプレートの需要を支え続けています。さらに、製薬業界やバイオテクノロジー業界は研究開発に多額の投資を行っており、これが転写テンプレートの需要を支えています。科学者は、遺伝子発現、タンパク質合成、細胞メカニズムの研究にIn-vitro転写テンプレートを使用しています。

In-vitro転写テンプレート市場-主要洞察

リサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）に約21.09%のCAGRで毎年成長すると予測されています。

製品別では、DNAテンプレートセグメントは、転写を促進する高い効率性により、2023年に最大の市場シェアを示すと予測されました。

用途別では、COVID-19やその他のウイルス感染症の流行が拡大していることから、2023年にはワクチンセグメントが主要用途セグメントとなりました。

疾患タイプ別では、肺がん、白血病、乳がんなどの流行により、2023年にはがん分野が主要疾患タイプとなりました。

地域別では、2023年に北米が主要な収益源でした。これは、研究開発と新薬開発における政府の支援によるものです。

In-vitro転写テンプレート市場-セグメンテーション分析：

In-vitro転写用テンプレートの世界市場は、製品、用途、疾患タイプ、地域に基づいてセグメント化されます。

市場は製品別に4つのカテゴリーに分けられ、DNAテンプレート、RNAテンプレート、テンプレートと転写キット、その他です。DNAテンプレートセグメントが市場を独占しています。DNAテンプレートは高効率であり、シーケンシングと転写プロセスにおいて堅牢であることが市場成長に寄与しています。

市場は用途別にワクチンと治療薬の2つに分類されます。ワクチンセグメントが市場を独占しています。ワクチンは主にウイルス感染を標的として使用され、他のタイプよりも効果が高いため、市場の成長を後押ししています。

疾患タイプ別では、がん、感染症、遺伝性疾患、生活習慣病、その他の5つのカテゴリーに分類されます。がんセグメントは市場を独占しており、予測期間中も高い優位性を維持すると予想されます。肺がん、乳がん、白血病の有病率の増加がセグメントの成長を補完しています。

In-vitro転写テンプレート市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。北米は世界市場で最大の収益シェアを占めています。米国は、特にRNAベースの治療薬やワクチンの開発において、確立されたバイオテクノロジーと製薬部門があるため、世界市場を独占しています。アジア太平洋では、バイオテクノロジー分野の成長、RNAベースの治療薬への投資の増加、バイオテクノロジーの研究開発に対する政府の支援により、中国がIVTテンプレート市場の主要地域として急速に台頭しています。ヘルスケアの革新に政府が注力し、世界の製薬企業との提携が進んでいることが市場を牽引しています。

In-vitro転写テンプレート市場-競合情勢：

In-vitro転写（IVT）テンプレート市場は、バイオテクノロジー業界と製薬業界の主要企業がRNAベースの技術革新に注力しており、競争が激しくなっています。これらの企業はRNA生産用の高品質転写テンプレートの開発に投資しており、mRNAワクチン、RNAベースの治療薬、遺伝子編集などの分野での進歩を可能にしています。主要企業は製薬会社と提携し、RNAベースのワクチンや治療薬の製造に不可欠なIVTコンポーネントを供給しています。TriLink、Aldevron、Merckなどの企業は、mRNAワクチンやRNAベースの医薬品の需要増に対応するため、特に高品質RNA製造のための製造能力拡大に多額の投資を行っています。

2023年9月、メルクはmRNAの開発、製造、商業化、製品試験の完全統合サービスを提供する最初のCTDMOとなりました。

2023年、医学研究評議会（MRC）や生物工学・生物科学研究評議会（BBSRC）などの英国の研究評議会は、RNA生物学やゲノミクスの基礎研究や応用研究に多額の資金を割り当てました。

目次

第1章 In-vitro転写テンプレート市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 In-vitro転写テンプレートの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 In-vitro転写テンプレート業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 In-vitro転写テンプレート市場：COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 In-vitro転写テンプレート市場情勢

  • In-vitro転写テンプレートの市場シェア分析：2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 In-vitro転写テンプレート市場- 製品別

  • 概要
    • 製品別のセグメントシェア分析
    • DNAテンプレート
    • RNAテンプレート
    • テンプレートと転写キット
    • その他

第8章 In-vitro転写テンプレート市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • ワクチン
    • 治療薬

第9章 In-vitro転写テンプレート市場- 疾患タイプ別

  • 概要
    • 疾病タイプ別のセグメントシェア分析
    • がん
    • 感染症
    • 遺伝性疾患
    • 生活習慣病
    • その他

第10章 In-vitro転写テンプレート市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- In-vitro転写テンプレート業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific
    • Merck KGaA
    • Promega Corporation
    • Agilent Technologies
    • New England Biolabs
    • Takara Bio Inc.
    • Synthego Corporation
    • TriLink BioTechnologies
    • Aldevron
    • Bio-Rad Laboratories
    • GenScript Biotech Corporation
    • Sigma-Aldrich
    • CellScript
    • QIAGEN NV
    • Lucigen Corporation
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV3865

REPORT HIGHLIGHT

In-vitro Transcription Templates Market size was valued at USD 251.43 Million in 2023, expanding at a CAGR of 21.09% from 2024 to 2032.

In-vitro transcription templates are DNA sequences used to synthesize RNA in a controlled laboratory setting outside of a living organism. These templates serve as the blueprints for RNA synthesis and are essential in experiments where researchers want to produce specific RNA molecules.

In-vitro Transcription Templates Market- Market Dynamics

Growing demand from RNA-based therapeutics & vaccines and increasing research in biotech is also expected to propel market demand

The development of RNA-based therapeutics, including small interfering RNA (siRNA) and antisense oligonucleotides (ASOs), has increased demand for high-quality RNA production. mRNA vaccines, like those developed for COVID-19 disease like Pfizer-BioNTech and Moderna, have significantly boosted interest in in-vitro transcription (IVT) templates. The ability to rapidly design and produce mRNA vaccines has made in-vitro transcription crucial in pharmaceutical development. The rise of gene-editing tools like CRISPR-Cas9 uses in-vitro transcription to generate guide RNA (gRNA), which is critical for genome editing applications.

As personalized medicine evolves, the ability to produce tailor-made RNA for individualized treatments like cancer immunotherapies drives the demand for efficient IVT template technology. The need for efficient production of RNA for biosensors, bioengineering applications, and novel biological circuits continues to support the demand for transcription templates. In addition, the pharmaceutical and biotechnology industries are investing heavily in R&D, which supports the demand for transcription templates. Scientists use in-vitro transcription templates to study gene expression, protein synthesis, and cellular mechanisms.

In-vitro Transcription Templates Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.09% over the forecast period (2024-2032)

Based on Product segmentation, the DNA templates segment was predicted to show maximum market share in the year 2023, owing to their higher efficiency in driving transcription.

Based on Application segmentation, vaccines segment was the leading Application segment in 2023, due to the growing prevalence of COVID-19 and other viral infections.

Based on Disease Type segmentation, cancer segment was the leading Disease Type segment in 2023, due to prevalence of lung cancer, leukemia, breast cancer, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the government support in research & new drugs development.

In-vitro Transcription Templates Market- Segmentation Analysis:

The Global In-vitro Transcription Templates Market is segmented on the basis of Product, Application, Disease Type, and Region.

The market is divided into four categories based on Product: DNA templates, RNA templates, templates & transcription kits, and others. The DNA templates segment dominates the market. DNA templates offer high efficiency & are robust in sequencing & transcription process which is contributing to market growth.

The market is divided into two categories based on Application: vaccines and therapeutics. The vaccines segment dominates the market. The vaccines are mainly used in targeting viral infections and are more effective than other type boosting market growth.

The market is divided into five categories based on Disease Type: cancer, infectious diseases, genetic diseases lifestyle diseases, and others. The cancer segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing prevalence of lung, breast cancer, leukemia are supplementing segment growth.

In-vitro Transcription Templates Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America held the largest revenue share in the global market. The U.S. dominates the global market due to its well-established biotechnology and pharmaceutical sectors, particularly in the development of RNA-based therapies and vaccines. In Asia Pacific, China is rapidly emerging as a key player in the IVT template market due to its growing biotech sector, increasing investments in RNA-based therapeutics, and government support for biotechnology R&D. Increased government focus on healthcare innovation and collaborations with global pharma companies are driving the market.

In-vitro Transcription Templates Market- Competitive Landscape:

The In-vitro Transcription (IVT) Templates market is significantly competitive, with several key players across the biotechnology and pharmaceutical industries focusing on innovations in RNA-based technologies. These companies are investing in developing high-quality transcription templates for RNA production, enabling advancements in areas like mRNA vaccines, RNA-based therapeutics, and gene editing. Key players are forming alliances with pharmaceutical companies to supply critical IVT components for the production of RNA-based vaccines and therapeutics. Companies like TriLink, Aldevron, and Merck are heavily investing in expanding their manufacturing capabilities, particularly for high-quality RNA production, to meet the growing demand for mRNA vaccines and RNA-based drugs.

In September 2023, Merck became the first CTDMO to offer fully integrated services for mRNA development, manufacturing, commercialization, and product testing.

In 2023, UK research councils such as the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC) allocated substantial funding for basic and applied research in RNA biology, genomics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Merck KGaA
  • Promega Corporation
  • Agilent Technologies
  • New England Biolabs
  • Takara Bio Inc.
  • Synthego Corporation
  • TriLink BioTechnologies
  • Aldevron
  • Bio-Rad Laboratories
  • GenScript Biotech Corporation
  • Sigma-Aldrich
  • CellScript
  • QIAGEN N.V.
  • Lucigen Corporation
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • DNA templates
  • RNA templates
  • Templates & Transcription Kits
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Vaccines
  • Therapeutics

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Cancer
  • Infectious diseases
  • Genetic diseases lifestyle diseases
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. In-vitro Transcription Templates Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. In-vitro Transcription Templates Market Snippet by Product
    • 2.1.2. In-vitro Transcription Templates Market Snippet by Application
    • 2.1.3. In-vitro Transcription Templates Market Snippet by Disease Type
    • 2.1.4. In-vitro Transcription Templates Market Snippet by Country
    • 2.1.5. In-vitro Transcription Templates Market Snippet by Region
  • 2.2. Competitive Insights

3. In-vitro Transcription Templates Key Market Trends

  • 3.1. In-vitro Transcription Templates Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. In-vitro Transcription Templates Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. In-vitro Transcription Templates Market Opportunities
  • 3.4. In-vitro Transcription Templates Market Future Trends

4. In-vitro Transcription Templates Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. In-vitro Transcription Templates Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. In-vitro Transcription Templates Market Landscape

  • 6.1. In-vitro Transcription Templates Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. In-vitro Transcription Templates Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. DNA templates
    • 7.1.3. RNA templates
    • 7.1.4. Templates & Transcription Kits
    • 7.1.5. Others

8. In-vitro Transcription Templates Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Vaccines
    • 8.1.3. Therapeutics

9. In-vitro Transcription Templates Market - By Disease Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 9.1.2. Cancer
    • 9.1.3. Infectious diseases
    • 9.1.4. Genetic diseases lifestyle diseases
    • 9.1.5. Others

10. In-vitro Transcription Templates Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. In-vitro Transcription Templates Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. In-vitro Transcription Templates Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. In-vitro Transcription Templates Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. In-vitro Transcription Templates Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. In-vitro Transcription Templates Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- In-vitro Transcription Templates Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Merck KGaA
    • 11.2.3. Promega Corporation
    • 11.2.4. Agilent Technologies
    • 11.2.5. New England Biolabs
    • 11.2.6. Takara Bio Inc.
    • 11.2.7. Synthego Corporation
    • 11.2.8. TriLink BioTechnologies
    • 11.2.9. Aldevron
    • 11.2.10. Bio-Rad Laboratories
    • 11.2.11. GenScript Biotech Corporation
    • 11.2.12. Sigma-Aldrich
    • 11.2.13. CellScript
    • 11.2.14. QIAGEN N.V.
    • 11.2.15. Lucigen Corporation
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us